Amanta Healthcare Limited, a pharmaceutical company engaged in development, manufacturing, and marketing of sterile liquid products, including both large and small volume parenterals (LVPs and SVPs), proposes to open its Initial Public Offering on September 01, 2025, aiming to raise ₹ 12,600.00 Lakhs (at upper price band) with shares to be listed on the NSE and BSE Platform.
The issue size is up to 1,00,00,000 equity shares with a face value of ₹ 10 each with a price band of ₹ 120 – ₹ 126 Per Equity Share.
- Issue Opens: September 1, 2025
- Issue Closes: September 3, 2025
- Face Value: Rs 10 each
- Price Band: Rs 120 – 126 per share
- Lot Size: 119 Shares
- Listing: BSE & NSE
The net proceeds from the IPO will be utilized for funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat, funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat, and general corporate purposes. The anchor portion will open on Friday, August 29, 2025 and issue will close on Wednesday, September 03, 2025.
Amanta Healthcare Limited, a pharmaceutical company engaged in developing, manufacturing, and marketing of sterile liquid products, including both large and small volume parenterals (LVPs and SVPs) using Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies, The Company serve’s six therapeutic segments such as fluid therapy – (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions.
The company also manufacture medical devices like irrigation solutions, first-aid products, and eye lubricants. Our packaging includes a wide range of closure systems and container volumes from 2 ml to 1000 ml. In FY25, The Company achieved a Revenue of ₹ 27,470.82 Lakhs, EBITDA of ₹ 6,105.37 Lakhs & PAT of ₹ 1,050.07 Lakhs








